Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

9 Jun 2021

Abstract excerpt

BACKGROUND: Glioma is the most common primary intracranial tumor and is associated with poor prognosis. Identifying effective biomarkers for glioma is particularly important. MXRA5, a secreted glycoprotein, is involved in cell adhesion and extracellular matrix remodeling and has been reported to be expressed in many cancers. However, the role and mechanism of action of MXRA5 in gliomas remain unclear. This study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34211612
DOI: 10.1155/2021/6680883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in GliomaPMID 34211612Read ↗

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in GliomasSemantic proximity Read ↗

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in gliomaSemantic proximity Read ↗

Molecular Insights and Prognosis Associated With RBM8A in GlioblastomaSemantic proximity Read ↗

Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in gliomaSemantic proximity Read ↗

Identification of SLC1A5 as a Novel Candidate Oncogene for Glioma and Its Involvement in the LGG Immune MicroenvironmentSemantic proximity Read ↗

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity Read ↗

Prognostic value and drug sensitivity of FBXL6 in gliomaSemantic proximity Read ↗

TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in GliomasSemantic proximity Read ↗

Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiformeSemantic proximity Read ↗

MR1 overexpression correlates with poor clinical prognosis in glioma patientsSemantic proximity Read ↗

RBM8A Promotes Glioblastoma Growth and Invasion Through the Notch/STAT3 PathwaySemantic proximity Read ↗

ITGA5 induces mesenchymal transformation to promote gliomas progression via PI3K/AKT/mTORC1 signaling pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.